1 Min Read
March 12 (Reuters) - iBio Inc:
* IBIO PATENT ISSUES IN CHINA ON PROTEIN GLYCOSYLATION MODIFICATION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.